Navigation Links
BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine

ATLANTA, May 20 /PRNewswire/ -- Germany will present itself as one of the world's leading regenerative medicine research locations at this year's BIO International Convention. Under the "Breakthroughs in Regenerative Medicines in Germany" banner, German experts will provide invaluable insight into the latest research results in the area of regenerative medicine in Germany. The German research landscape and the regulatory framework conditions will be introduced in a presentation in which the most recent industry successes will also be demonstrated.

Dr. Manfred Rudiger, CEO of Frankfurt-based t2cure GmbH, and Prof. Dr. Georg N. Duda, Vice Director of the Berlin-Brandenburg Center for Regenerative Therapies (BCRT), will also speak at the Germany Trade & Invest-organized event. Both are experts and active partners in the German research and enterprise landscape in the area of regenerative medicine.

Regenerative medicine offers rich and varied potential at a time when western social welfare states are confronted with the problem of rapidly aging populations and overloaded health systems. It is generally expected that not only should the quality of life of the patient be improved by regenerative treatments, but also that health systems be sustainably disburdened by eliminating protracted aftercare and complications.

Germany takes center-stage in the presentation as an innovative location with favorable research conditions. In this respect, highlighted in particular is the excellent cross-linking among German universities as well as with other research and development institutions. In combination with the strong political will to actively promote promising regenerative medicine projects, the high quality of existing research networks provide a strong argument for investment in Germany.

As well as highlighting German initiative-led successes in regenerative medicine to date, the event at the Georgia World Congress Center in Atlanta will also illustrate future growth potential within the sector in Germany.

The annual BIO International Convention is the largest global event for the biotechnology industry. It takes place at changing locations within the USA and attracts participating exhibitors from around 50 countries. This year's BIO takes place until Thursday, May 21, 2009, at the Georgia World Congress Centers in Atlanta. The German Pavilion is located in Building B, Hall B2.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises and supports foreign companies seeking to expand into the German market and assists companies established in Germany looking to enter foreign markets.

    Media Contact:
    Eva Henkel
    Phone: +49(0)30-200099-173
    Fax:   +49(0)30-200099-111

SOURCE Germany Trade and Invest
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
3. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
4. Arrow International Files and Mails Definitive Proxy Materials
5. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
6. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
7. Viragen International to Reverse Split Its Common Stock
8. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
9. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
10. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
11. Biosafety and Biosecurity International Conference 2007 to be held in Abu Dhabi from November 12 to 14
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... 23, 2016 Andrew ... Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
Breaking Biology Technology:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
Breaking Biology News(10 mins):